Neil Desai, EXECUTIVE CHAIRMAN at Aadi Bioscience, Inc. (AADI), sold 40,000 shares at $1.45 ($57K) on 2024-07-01, disclosed to the SEC on 2024-07-02.
Scheduled sale ($57k) by EXECUTIVE CHAIRMAN under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.45 | 31,348 | $45K | 79.7% |
| 2 | $1.34 | 8,652 | $12K | 20.3% |
| Total | $1.43 avg | 40,000 | $57K | 100% |
| Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |
| AADI | SELL | 2024-04-03 | $91K | — | Filing → |